Cargando…
Small molecule-mediated disruption of ribosome biogenesis synergizes with FGFR inhibitors to suppress glioma cell growth
BACKGROUND: High-grade gliomas are malignant brain tumors characterized by aggressiveness and resistance to chemotherapy. Prognosis remains dismal, highlighting the need to identify novel molecular dependencies and targets. Ribosome biogenesis (RiBi), taking place in the nucleolus, represents a prom...
Autores principales: | Zisi, Asimina, Kanellis, Dimitris C, Moussaud, Simon, Karlsson, Ida, Carén, Helena, Bräutigam, Lars, Bartek, Jiri, Lindström, Mikael S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237440/ https://www.ncbi.nlm.nih.gov/pubmed/36583853 http://dx.doi.org/10.1093/neuonc/noac286 |
Ejemplares similares
-
Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward
por: Zisi, Asimina, et al.
Publicado: (2022) -
The antimalarial drug amodiaquine stabilizes p53 through ribosome biogenesis stress, independently of its autophagy-inhibitory activity
por: Espinoza, Jaime A., et al.
Publicado: (2019) -
The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output
por: Kanellis, Dimitris C., et al.
Publicado: (2021) -
Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET
por: Kanellis, Dimitris C., et al.
Publicado: (2023) -
p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways
por: Lindström, Mikael S., et al.
Publicado: (2022)